NGS 기반 RNA 시퀀싱 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

NGS-Based RNA-Sequencing Trends and Forecast

The future of the global NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospital and clinic, and pharmaceutical & biotechnology markets. The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030 with a CAGR of 17.6% from 2024 to 2030. The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.

A more than 150-page report is developed to help in your business decisions.

NGS-Based RNA-Sequencing by Segment

The study includes a forecast for the global NGS-based RNA-sequencing by product type, technology, application, end use, and region.

NGS-Based RNA-Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Sample Preparation Products
• RNA-sequencing Platforms and Consumables
• RNA-sequencing Services
• Data Analysis, Storage & Management

NGS-Based RNA-Sequencing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
• Nanopore Sequencing

NGS-Based RNA-Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Expression Profiling Analysis
• Small RNA-Sequencing
• De Novo Transcriptome Assembly
• Variant Calling & Transcriptome Epigenetics
• Others

NGS-Based RNA-Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Research and Academia
• Hospitals and Clinics
• Pharmaceutical & Biotechnology
• Others

NGS-Based RNA-Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of NGS-Based RNA-Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies NGS-based RNA-sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the NGS-based RNA-sequencing companies profiled in this report include-

• Illumina
• Thermo Fischer Scientific
• Oxford Nanopore Technologies
• Agilent Technologies
• BGI

NGS-Based RNA-Sequencing Market Insights

Lucintel forecasts that expression profiling analysis will remain the largest region due to its increasing demand in gene discovery, differential gene expression analysis, and transcriptome profiling.

North America will remain the largest region due to high demand for personalized medicine, existence of robust healthcare infrastructure, and presence of key players in the region.

Features of the Global NGS-Based RNA-Sequencing Market

Market Size Estimates: Ngs-based RNA-sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ngs-based RNA-sequencing market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Ngs-based RNA-sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the NGS-based RNA-sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the NGS-based RNA-sequencing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the NGS-based RNA-sequencing market size?

Answer: The global NGS-based RNA-sequencing market is expected to reach an estimated $8.4 billion by 2030.

Q.2 What is the growth forecast for NGS-based RNA-sequencing market?

Answer: The global NGS-based RNA-sequencing market is expected to grow with a CAGR of 17.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the NGS-based RNA-sequencing market?

Answer: The major drivers for this market are escalating demand for personalized medicine and rising awareness of the benefits of NGS-RNA-sequencing.

Q4. What are the major segments for NGS-based RNA-sequencing market?

Answer: The future of the NGS-based RNA-sequencing market looks promising with opportunities in the research and academia, hospitals and clinics, and pharmaceutical & biotechnology markets.

Q5. Who are the key NGS-based RNA-sequencing market companies?

Answer: Some of the key NGS-based RNA-sequencing companies are as follows:

• Illumina
• Thermo Fischer Scientific
• Oxford Nanopore Technologies
• Agilent Technologies
• BGI

Q6. Which NGS-based RNA-sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that expression profiling analysis will remain the largest region due to its increasing demand in gene discovery, differential gene expression analysis, and transcriptome profiling.

Q7. In NGS-based RNA-sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high demand for personalized medicine, existence of robust healthcare infrastructure, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the NGS-based RNA-sequencing market by product type (sample preparation products, RNA-sequencing platforms and consumables, RNA-sequencing services, and data analysis, storage & management), technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing), application (expression profiling analysis, small RNA-sequencing, de novo transcriptome assembly, variant calling & transcriptome epigenetics, and others), end use (research and academia, hospitals and clinics, pharmaceutical & biotechnology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global NGS-Based RNA-Sequencing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global NGS-Based RNA-Sequencing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global NGS-Based RNA-Sequencing Market by Product Type
  • 3.3.1: Sample Preparation Products
  • 3.3.2: RNA-sequencing Platforms and Consumables
  • 3.3.3: RNA-sequencing Services
  • 3.3.4: Data Analysis, Storage & Management
• 3.4: Global NGS-Based RNA-Sequencing Market by Technology
  • 3.4.1: Sequencing by Synthesis
  • 3.4.2: Ion Semiconductor Sequencing
  • 3.4.3: Single-molecule Real-time Sequencing
  • 3.4.4: Nanopore Sequencing
• 3.5: Global NGS-Based RNA-Sequencing Market by Application
  • 3.5.1: Expression Profiling Analysis
  • 3.5.2: Small RNA-Sequencing
  • 3.5.3: De Novo Transcriptome Assembly
  • 3.5.4: Variant Calling & Transcriptome Epigenetics
  • 3.5.5: Others
• 3.6: Global NGS-Based RNA-Sequencing Market by End Use
  • 3.6.1: Research and Academia
  • 3.6.2: Hospitals and Clinics
  • 3.6.3: Pharmaceutical & Biotechnology
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global NGS-Based RNA-Sequencing Market by Region
• 4.2: North American NGS-Based RNA-Sequencing Market
  • 4.2.1: North American NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
  • 4.2.2: North American NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
• 4.3: European NGS-Based RNA-Sequencing Market
  • 4.3.1: European NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
  • 4.3.2: European NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
• 4.4: APAC NGS-Based RNA-Sequencing Market
  • 4.4.1: APAC NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
  • 4.4.2: APAC NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others
• 4.5: ROW NGS-Based RNA-Sequencing Market
  • 4.5.1: ROW NGS-Based RNA-Sequencing Market by Application: Expression Profiling Analysis, Small RNA-Sequencing, De Novo Transcriptome Assembly, Variant Calling & Transcriptome Epigenetics, and Others
  • 4.5.2: ROW NGS-Based RNA-Sequencing Market by End Use: Research and Academia, Hospitals and Clinics, Pharmaceutical & Biotechnology, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Product Type
  • 6.1.2: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Technology
  • 6.1.3: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Application
  • 6.1.4: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by End Use
  • 6.1.5: Growth Opportunities for the Global NGS-Based RNA-Sequencing Market by Region
• 6.2: Emerging Trends in the Global NGS-Based RNA-Sequencing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global NGS-Based RNA-Sequencing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global NGS-Based RNA-Sequencing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Illumina
• 7.2: Thermo Fischer Scientific
• 7.3: Oxford Nanopore Technologies
• 7.4: Agilent Technologies
• 7.5: BGI